Masong, John Mark E.
HRN: 11-43-49 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2023
CEFTRIAXONE 1G (VIAL)
01/18/2023
01/24/2023
IV
1g
Q 24H
Lacerated Wound, Fronto-parietal Area, ER
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes